260 related articles for article (PubMed ID: 24012623)
1. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
[TBL] [Abstract][Full Text] [Related]
2. 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
Kolasiewicz W; Kuter K; Berghauzen K; Nowak P; Schulze G; Ossowska K
Brain Res; 2012 Oct; 1477():59-73. PubMed ID: 22902616
[TBL] [Abstract][Full Text] [Related]
3. Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.
Kolasiewicz W; Kuter K; Nowak P; Pastuszka A; Ossowska K
Cerebellum; 2011 Jun; 10(2):267-80. PubMed ID: 21279489
[TBL] [Abstract][Full Text] [Related]
4. Glutamate neurons in the substantia nigra compacta and retrorubral field.
Yamaguchi T; Wang HL; Morales M
Eur J Neurosci; 2013 Dec; 38(11):3602-10. PubMed ID: 24102658
[TBL] [Abstract][Full Text] [Related]
5. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
6. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
[TBL] [Abstract][Full Text] [Related]
7. Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.
Lee CY; Lee CH; Shih CC; Liou HH
Biochem Pharmacol; 2008 Oct; 76(9):1155-64. PubMed ID: 18761327
[TBL] [Abstract][Full Text] [Related]
8. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
11. 6-OHDA induced calcium influx through N-type calcium channel alters membrane properties via PKA pathway in substantia nigra pars compacta dopaminergic neurons.
Qu L; Wang Y; Zhang HT; Li N; Wang Q; Yang Q; Gao GD; Wang XL
Neurosci Lett; 2014 Jul; 575():1-6. PubMed ID: 24861516
[TBL] [Abstract][Full Text] [Related]
12. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
13. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat.
Nair-Roberts RG; Chatelain-Badie SD; Benson E; White-Cooper H; Bolam JP; Ungless MA
Neuroscience; 2008 Apr; 152(4):1024-31. PubMed ID: 18355970
[TBL] [Abstract][Full Text] [Related]
14. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
15. Bilateral nigral 6-hydroxydopamine lesions increase the amount of extracellular dopamine in the nucleus accumbens.
van Oosten RV; Verheij MM; Cools AR
Exp Neurol; 2005 Jan; 191(1):24-32. PubMed ID: 15589509
[TBL] [Abstract][Full Text] [Related]
16. Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.
Zeng X; Shen H; Zhao J; Cai Q; Wang C; Xu Q
Brain Res; 2012 Apr; 1450():166-73. PubMed ID: 22424788
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
19. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
[TBL] [Abstract][Full Text] [Related]
20. Glutamate neurons within the midbrain dopamine regions.
Morales M; Root DH
Neuroscience; 2014 Dec; 282():60-8. PubMed ID: 24875175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
